Tickers

1. Composite Trajectory Verdict

All three statements carry roughly equal weight for this industrial distributor: earnings reflect pricing and volume execution, cash flow funds the acquisition-and-return model, and the balance sheet shows the capacity to sustain both.

Composite Trajectory: Improving

Annual results show consistent top-line growth (+8.8% in FY2026, +1.9% in FY2025), operating margin expansion (11.1% vs. 10.9% in FY2025), and rising diluted EPS ($10.95 vs. $10.12). Operating cash flow remains high ($484M in FY2026) despite a modest working-capital headwind, and free cash flow is stable near $460M. The balance sheet has deleveraged sharply — total debt fell from $572M to $262M, and net indebtedness is below 0.2x EBITDA — while equity grew slightly. The only offsets are a lower current ratio (2.6x vs. 3.3x) and a cash drawdown driven by voluntary debt repayment and accelerated share repurchases, not operating distress.

2. Red Flags

• Operating cash flow declined $8.3M in FY2026 despite a $21.5M rise in net income, driven by a $65.8M working-capital increase (primarily $61.5M higher receivables) (10-K FY2026, Consolidated Statements of Cash Flows; MD&A Liquidity and Capital Resources).
• Nine-month operating cash flow fell 7.6% YoY ($319.1M vs. $345.3M) while nine-month net income rose 3.8% (10-Q 2026-03-31, Condensed Statements of Cash Flows; Condensed Statements of Consolidated Income).
• Current ratio dropped from 3.3x to 2.6x and cash fell 67% ($388M to $127M) as the company repaid $310M of revolver debt and spent $317M on buybacks in FY2026 (10-K FY2026, Consolidated Balance Sheets; MD&A Liquidity and Capital Resources).
• Quarterly operating margin compressed slightly: Q3 FY2026 11.0% vs. 11.1% in Q3 FY2025; nine-month margin 10.8% vs. 10.9% (10-Q 2026-03-31, Condensed Statements of Consolidated Income).
• Q3 FY2026 net income was flat YoY ($99.8M vs. $99.8M) despite 7.3% revenue growth (10-Q 2026-03-31, Condensed Statements of Consolidated Income).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Improving

Annual net sales grew 8.8% to $4.97B in FY2026 (vs. $4.56B in FY2025), with organic growth of 5.4% (10-K FY2026, MD&A Results of Operations). Gross margin held at 30.3% for the second consecutive year (10-K FY2026, Consolidated Statements of Operations). Operating margin expanded to 11.1% from 10.9%, and net income rose 5.5% to $414.5M (10-K FY2026, Consolidated Statements of Operations). Diluted EPS increased 8.2% to $10.95, aided by a 2.6% reduction in weighted-average diluted shares (10-K FY2026, Consolidated Statements of Operations). Quarterly trends are mixed: Q3 FY2026 revenue rose 7.3% but operating margin dipped 10 bps and net income was unchanged; however, nine-month net income still grew 3.8% and diluted EPS rose 6.3% (10-Q 2026-03-31, Condensed Statements of Consolidated Income).

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Stable

FY2026 operating cash flow of $484.1M was only $8.3M below the FY2025 level of $492.4M, and well above FY2024's $371.4M (10-K FY2026, Consolidated Statements of Cash Flows). Free cash flow (operating cash flow minus capex) was ~$460M in both FY2026 and FY2025 (capex $23.6M vs. $27.2M) (10-K FY2026, Consolidated Statements of Cash Flows). Nine-month operating cash flow declined to $319.1M from $345.3M YoY, reflecting a $55.3M working-capital outflow versus a $5.4M inflow a year earlier (10-Q 2026-03-31, Condensed Statements of Cash Flows). Investing outflows dropped sharply as acquisition spending fell to $11.4M from $293.4M in FY2025 and to $11.4M from $273.3M in the nine-month periods (10-K FY2026, Consolidated Statements of Cash Flows; 10-Q 2026-03-31, Condensed Statements of Cash Flows). Financing outflows surged due to $310M debt repayment and $317M share repurchases in FY2026 (10-K FY2026, Consolidated Statements of Cash Flows).

5. Balance Sheet Assessment

Balance Sheet Trajectory: Improving

Total debt was cut by 54% to $262.3M at June 30, 2026 from $572.3M a year earlier, with the revolver balance falling from $384M to $74M (10-K FY2026, Consolidated Balance Sheets; Note 6). The company’s net leverage is below 0.2x EBITDA, far under the 3.75x covenant (10-K FY2026, Note 6). Shareholders’ equity rose to $1.86B from $1.84B despite $317M of buybacks, supported by $414M net income (10-K FY2026, Consolidated Balance Sheets; Consolidated Statements of Shareholders' Equity). Receivables grew to $831M from $770M (DSO improved to 55.3 from 56.6 days) and inventory turnover on average cost improved to 4.5x from 4.3x (10-K FY2026, MD&A Accounts Receivable Analysis; Inventory Analysis). The trade-offs are a lower cash balance ($127M vs. $388M), a reduced current ratio (2.6x vs. 3.3x), and a $255M decline in working capital, all driven by the deliberate debt paydown and repurchase program (10-K FY2026, MD&A Liquidity and Capital Resources).

6. Data Gaps

• Standalone Q4 FY2026 results (not separately filed; only full-year 10-K available).
• Standalone Q1 and Q2 FY2026 quarterly income statements and cash flows (10-Qs for 2025-09-30 and 2025-12-31 are truncated in the provided materials).
• Organic revenue growth breakdown by segment for quarterly periods (only annual organic breakdown provided in 10-K MD&A).
• Segment-level cash flow statements (only consolidated cash flows provided).
• Longer historical trends prior to FY2024 (only three fiscal years presented in 10-K).